ESC 365 - Lipid lowering treatment for selected patient populations.

Open Access

Lipid lowering treatment for selected patient populations.

Session: 2019 ESC/EAS Guidelines on Dyslipidaemias

Topic: Drug therapy

Speaker: Professor F. Mach (Geneva, CH)

Event: ESC CONGRESS 2019

Presentation

About the speaker

Professor Francois Mach

Geneva University Hospitals, Geneva (Switzerland)

20 presentations

1 follower

3 more presentations in this session

Risk stratification for atherosclerotic cardiovascular disease.

Speaker: Professor B. Ference (Cambridge, GB)

Imaging to improve selection of patients for lipid-lowering treatment.

Speaker: Doctor V. Delgado (Barcelona, ES)

Formulating appropriate lipid-lowering treatment goals and strategies.

Speaker: Professor A. Catapano (Milan, IT)

Access the full session

2019 ESC/EAS Guidelines on Dyslipidaemias

Speakers: Professor F. Mach, Professor B. Ference, Doctor V. Delgado, Professor A. Catapano

About the event

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Related content

ACVC Premium Access

Pathophysiology and evolving definition of cardiogenic shock.

19 March 2022

ESC Premium Access

Aortic regurgitation.

27 August 2021

ESC Premium Access

When is secondary mitral regurgitation severe?

27 August 2021

This platform is supported by